Molecular Imaging

Nuclear imaging, also called molecular imaging, includes positron emission computed tomography (PET) and single photon emission computed tomography (SPECT) imaging. This section includes radiopharmaceuticals and tracers, PET-CT, SPECT-CT, and PET-MRI. Molecular imaging includes the field of nuclear medicine, which uses very small amounts of radioactive materials, or radiopharmaceuticals, to diagnose and treat disease.

Markus Schwaiger, MD, receives SNMMI Georg Charles de Hevesy Nuclear Pioneer Award
News | PET Imaging
Markus Schwaiger, MD, receives SNMMI Georg Charles de Hevesy Nuclear Pioneer Award

June 21, 2022 — Markus Schwaiger, MD, a scientist known for his contributions to cardiac PET imaging, has been named as ...

Time June 21, 2022
arrow
SNMMI announces Krystle W. Glasgow, MIS, CNMT, NMTCB(CT), NMAA, FSNMMI-TS, as president of the Technologist Section during 2022 Annual Meeting. Image Courtesy of SNMMI
News | SNMMI
SNMMI Announces President of the Technologist Section During 2022 Annual Meeting

June 21, 2022 — Krystle W. Glasgow, MIS, CNMT, NMTCB(CT), NMAA, FSNMMI-TS, instructor and clinical coordinator at the ...

Time June 20, 2022
arrow
SNMMI Elects Cathy Sue Cutler, PhD, FSNMMI, as Vice President-Elect at 2022 Annual Meeting
News | SNMMI
SNMMI elects Cathy Sue Cutler, PhD, FSNMMI, as Vice President-Elect at 2022 Annual Meeting

June 16, 2022 — Cathy Sue Cutler, PhD, FSNMMI, director of the medical isotope research and production program at ...

Time June 16, 2022
arrow
System geometry, imaging mechanism, and performance evaluation of a self-collimating SPECT for fast dynamic cardiac imaging
News | SPECT Imaging
Revolutionary Technology Shortens Cardiac Scan Time, Provides High-quality SPECT Images

June 15, 2022 — A cardiac SPECT imaging system performs scans 10 to 100 times faster than current SPECT systems ...

Time June 15, 2022
arrow
Representative case with acute anterior wall myocardial infarction: Myocardial perfusion images using 99mTc-tetrofosmin at rest (first row), 68Ga-FAPI-46 PET (second row), late gadolinium enhancement (LGE) from cardiac magnetic resonance (third row) and schematic drawings of the left ventricle (fourth row). Area of fibroblast activation exceeds infarct area and LGE signal, most common type of myocardial FAP-distribution. Bottom left: Mean areas of perfusion defect, FAPI-signal and LGE of 35 studied patients
News | PET Imaging
SNMMI Image of the Year: New Biomarker Predicts Severity of Cardiac Remodeling After Heart Attack

June 15, 2022 — Poor functional outcomes after a heart attack can be predicted with a new PET imaging agent, 68Ga-FAPI ...

Time June 15, 2022
arrow
Cardiac positron emission tomography (PET) perfusion images for two representative patients. Both patients had similar demographic characteristics. Neither patient had significant perfusion abnormalities as shown in the figure. Patient A had mild sleep apnea while patient B had severe obstructive sleep apnea. The corrected myocardial flow reserve (MFR) for patient A was normal at 3.24 while for patient B it was severely abnormal at 1.22.
News | PET Imaging
PET Imaging Confirms Link Between Obstructive Sleep Apnea and Heart Blood Flow Impairment

June 15, 2022 — Patients with severe obstructive sleep apnea (OSA) are less able to increase blood flow to the heart ...

Time June 15, 2022
arrow
SNMMI Names Helen Nadel, MD, FRCPC, as President-Elect at 2022 Annual Meeting
News | SNMMI
SNMMI Names Helen Nadel, MD, FRCPC, as President-Elect at 2022 Annual Meeting

June 15, 2022 — Helen Nadel, MD, FRCPC, director of pediatric nuclear medicine at Lucile Packard Children’s Hospital at ...

Time June 15, 2022
arrow
Heat maps of PSMA PET prostatic fossa recurrence in patients with recurrence limited to the prostate fossa (miTr N0 M0, n=127), pelvic nodal disease (miTr N1 M0, n=30), distant organs/extra-pelvic nodal disease (miTr N0 M1, n=32) and pelvic nodal plus distant organs/extra-pelvic nodal disease (miTr N1 M1, n=37). The yellow contour represents the RTOG CTV
News | Prostate Cancer
PSMA PET Highlights Need for Updated Prostate Cancer Therapy Guidelines

June 15, 2022 — Current guidelines used to plan salvage radiation treatments in patients with local recurrence of ...

Time June 15, 2022
arrow
Representative axial image from a test set imaging study. From top left to bottom right: CT (A), NAC-PET (B), original AC-PET (C), AI-generated AC-PET (D). The blue arrow indicates one lesion that was observed in both images, and the red arrow indicates a lesion that was missed (i.e., not de-tected by expert nuclear medicine physicians) in AI image. NAC = Non-Attenuation Corrected. AC = Attenuation-Corrected
News | PET-CT
Virtual CT Scans Cut Patient Radiation Exposure in Half During PET/CT Studies

June 14, 2022 — A novel artificial intelligence method can be used to generate high-quality “PET/CT” images and ...

Time June 14, 2022
arrow
The Society of Nuclear Medicine and Molecular Imaging (SNMMI) announced the creation of the Mars Shot Fund, an initiative to raise $100 million to help pay for research into nuclear medicine, molecular imaging, and therapy.
News | SNMMI
SNMMI Launches Mars Shot Fund for Nuclear Medicine Research

June 14, 2022 — The Society of Nuclear Medicine and Molecular Imaging (SNMMI) announced the creation of the Mars Shot ...

Time June 14, 2022
arrow
SNMMI Elects Munir Ghesani, MD, FACNM, FACR, as President at 2022 Annual Meeting
News | SNMMI
SNMMI elects Munir Ghesani, MD, FACNM, FACR, as President at 2022 Annual Meeting

June 14, 2022 — Munir Ghesani, MD, FACNM, FACR, chief of nuclear medicine and molecular imaging at Mount Sinai Health ...

Time June 14, 2022
arrow
Offers enhanced SPECT and CT imaging functionalities, including 64-slice CT and automated SPECT motion correction, as well as automated workflow
News | SPECT-CT
Siemens Healthineers Announces FDA Clearance of Symbia Pro.specta SPECT/CT Scanner

June 13, 2022 — Siemens Healthineers has announced the Food and Drug Administration (FDA) clearance of the Symbia Pro ...

Time June 13, 2022
arrow
SpectronRx, a leading contract development and manufacturing organization (CDMO) for the life sciences industry that specializes in radiopharmaceuticals, today announced that it will showcase its new Actinium-225 production facility during this year’s annual Society of Nuclear Medicine and Molecular Imaging (SNMMI) meeting being held June 11-14 in Vancouver, British Columbia, Canada.
News | Radiopharmaceuticals and Tracers
SpectronRx to Showcase New Facility for the Global Supply of Actinium-225 at SNMMI 2022

June 13, 2022 — SpectronRx, a leading contract development and manufacturing organization (CDMO) for the life sciences ...

Time June 13, 2022
arrow
At the Society of Nuclear Medicine & Molecular Imaging (SNMMI) 2022 Annual Meeting, GE Healthcare showcases cutting-edge solutions spanning the care continuum and enabling theranostics in prostate cancer
News | Prostate Cancer
GE Healthcare’s Total Molecular Imaging Solutions Enable Precision Health and Theranostics for Personalized Prostate Cancer Care

June 10, 2022 — GE Healthcare provides cutting-edge molecular imaging solutions that enable and increase access to ...

Time June 10, 2022
arrow
Mobile radiology represents a transforming concept that is evolving rapidly in line with notable advancements in the point-of-care (POC) testing arena.
Feature | Digital Radiography (DR) | By ResearchAndMarkets
Global Mobile Imaging Services Market Trajectory and Analytics Report

The "Mobile Imaging Services - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's ...

Time June 09, 2022
arrow
Curie Therapeutics will be provided with priority access to NorthStar’s high purity non-carrier added (n.c.a.) Ac-225, which will be used to advance its multimodal pipeline of precision radiopharmaceuticals to address broad unmet needs in treatment of patients with solid tumors
News | Radiopharmaceuticals and Tracers
NorthStar Medical Radioisotopes and Curie Therapeutics Announce Priority Access Supply Agreement for Therapeutic Radioisotope Actinium-225 (Ac-225)

June 8, 2022 — NorthStar Medical Radioisotopes, LLC (‘NorthStar’), a global innovator in the development, production and ...

Time June 08, 2022
arrow
News | PET Imaging
Blue Earth Diagnostics Completes Patient Accrual in Phase 3 REVELATE Clinical Trial of 18F-Fluciclovine PET Imaging for Detection of Recurrent Brain Metastases

June 8, 2022 — Blue Earth Diagnostics, a Bracco company and recognized leader in the development and commercialization ...

Time June 08, 2022
arrow
Today, GE Healthcare issued a statement that it expects production capacity from its Shanghai facility to be close to 100% starting Monday, June 6, following the easing of local COVID-19 restrictions.
News | Contrast Media
GE Healthcare Issues Update on Iodinated Contrast Media

June 2, 2022 — Today, GE Healthcare issued a statement that it expects production capacity from its Shanghai facility to ...

Time June 02, 2022
arrow
Top 10 ITN content for the Month of May 2022
Feature | Radiology Business | By Melinda Taschetta-Millane
ITN's Top 10 Most-read Content for May

Here is what you and your colleagues found to be most interesting in the field of medical imaging during the month of ...

Time June 01, 2022
arrow
Patented artificial intelligence technology eliminates the need for gadolinium-based contrast agents in MRI exams
News | Artificial Intelligence
Imaging Biometrics Submits FDA 510(k) Application for IB Zero G

May 31, 2022 — Imaging Biometrics, LLC (IB), a subsidiary of IQ-AI Limited, announced it has submitted an FDA 510(k) ...

Time May 31, 2022
arrow
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now